Hans Ageland

Hans Ageland founded Esperion Therapeutics, Inc. in 1998, where he worked as Vice President-Production and Redwood Pharma AB in 2012, where he is working as Chief Operating Officer from 2012.
Mr. Ageland also founded Unitech Pharma AB, Artery Therapeutics, Inc., Trobio AB, and Bioage AB, where he worked as Chief Executive Officer.
Mr. Ageland also currently works at Ateljé Grön AB, as Deputy Director and Daniel & Sebastian Byggentreprenad AB, as Deputy Director.
Mr. Ageland also formerly worked at Medivir AB, as Vice President-Production and Pharmacia AB, as Project Manager.
Mr. Ageland received his graduate degree from Royal Institute of Technology.